Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: Lupin - What They Never Told You

Stocks in news: Tata Motors, RVNL, Eicher Motors, Mazagon Dock and Lupin

Indian equity markets experienced volatility, with the Nifty 50 extending its losing streak for four weeks. Escalating US-Iran hostilities pushed crude oil prices higher, impacting overall market sentiment. Several companies, including Tata Motors and Rail Vikas Nigam, are expected to be active on Monday. Mazagon Dock Shipbuilders and Eicher Motors…

The Economic Times

Lupin gets USFDA approval for Modafinil tablets to treat excessive sleepiness

Pharmaceutical major Lupin announced its USFDA approval for Modafinil tablets. These tablets are used to treat excessive sleepiness in adult patients. The approved drug is bioequivalent to Provigil Tablets of Nuvo Pharmaceuticals. Modafinil tablets had estimated annual sales of USD 70.7 million in the United States. Lupin currently operates 15…

The Economic Times

Lupin share falls 2%; Citi downgrades to Sell, cuts target price to Rs 2,050

Lupin shares fell after Citi downgraded the stock to ‘Sell’ and cut its target price to Rs 2,050. The brokerage expects weaker US base-business sales, margin pressure and limited benefits from new products. Citi also reduced FY27 EPS estimates by 14%. Lupin’s technical indicators remain bearish despite its oversold RSI…

The Economic Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Lupin arm to commercialise YUVEZZI eye drop across key European markets

Lupin's VISUfarma BV has secured exclusive rights for YUVEZZI in key European markets. This ophthalmic product treats loss of clear close-up vision in adults. VISUfarma will undertake regulatory activities and commercialization of the eye drop. The agreement includes a strategic investment and potential milestone payments. YUVEZZI represents a significant advancement…

The Economic Times

Lupin shares in focus after USFDA nod for drug to treat excessive daytime sleepiness

Lupin received USFDA approval for generic Pitolisant Tablets, strengthening its US portfolio and specialty generics presence. Shares remain technically weak despite strong long-term returns, with FIIs raising their stake while mutual fund holdings declined. The stock trades below most key moving averages, keeping near-term momentum subdued despite the positive regulatory…

The Economic Times

Lupin Q1 PAT rises 16 pc at Rs 1,417 cr

Lupin Ltd has reported a remarkable sixteen percent surge in profit after tax for the first quarter, showcasing their continued success. The firm experienced considerable growth in consolidated total revenue from operations, largely driven by a staggering forty-two percent increase in sales in the US market. Moreover, sales in India…

The Economic Times

More Than 2.5 Million Bottles of a Prescription Steroid Eye Drop Have Been Recalled: Here Is How to Check Yours

The FDA issued a Class II recall of 2.53 million bottles of prednisolone acetate eye drops by Lupin over foreign substance contamination. Check your lot number now.

Medical Daily

Read news from The Economist, FT, and more,
with one subscription

More Than 2.5 Million Bottles of a Prescription Steroid Eye Drop Have Been Recalled: Here Is How to Check Yours

The FDA issued a Class II recall of 2.53 million bottles of prednisolone acetate eye drops by Lupin over foreign substance contamination. Check your lot number now.

Medical Daily

Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investors

Donald Trump's announcement of tariffs of up to 200% on pharmaceutical imports triggered a selloff in Indian pharma stocks. However, analysts believe the long-term impact could be limited, citing India's manufacturing cost advantage, US-based production facilities of several drugmakers and uncertainty over how and when the tariffs will be implemented.

The Economic Times

Sun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028

Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff plan on imported generic drugs. While generics will remain tariff-free for two years, duties will rise to 100% from August 2028 and 200% from August 2029, weighing…

The Economic Times

FDA Issues Class II Recall of 2.5 Million Eye Drop Bottles Over Foreign Material Contamination

FDA recalls 2.5 million prednisolone acetate eye drop bottles made by Lupin over foreign material contamination. Class II designation. What patients should do.

Medical Daily

Contaminated Eye Drops? Recent Recalls Raise New Questions About How Sterility Failures Can Threaten Vision

A nationwide recall of millions of prescription eye drops highlights how sterility failures and contamination can threaten vision and eye health.

Medical Daily

Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal Manchanda

India's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and consumer healthcare. While US FDA approvals for complex generics remain a challenge, innovation and contract manufacturing offer significant future profit pools. Experts anticipate biosimilars could generate substantial revenue, and despite a slow start, GLP-1…

The Economic Times

Bernstein initiates coverage on 6 pharma stocks, cites 3 major tailwinds for healthcare sector

Bernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future growth for the Indian healthcare sector. Key drivers include AI-led innovation, incremental advancements in niche areas, and improved quality culture. Attractive valuations also support this positive outlook for the…

The Economic Times

Get all your
news in one place.

100's of premium titles.
One news app.

Homes & Gardens

I constantly return to these 10 Netflix shows for interior design inspiration – the unique sets are eternally stylish

Bingewatching just got 10X chicer – these shows are filled with decor quirks inspired by corners of the world, from La Jolla to Tuscany

The Guardian - US

A Silicon Valley nudist resort is on sale for $30m – but will its new owner ‘go textile’?

Members are in limbo as Lupin Lodge is on the market after nearly 90 years – with next buyer likely to require clothes

WhatToWatch

Take Two: best Netflix original series

Which Netflix original series won the most Emmys for a single season? Which of Netflix's acclaimed limited series is higher rated on IMDb?

Broadcasting & Cable

Netflix's Older Seasons Average an 86% Viewership Boost When New Episodes Drop

Ampere Analysis notes that the season 1 and 2 audience French crime-thriller series 'Lupin' increased five fold following the release of season 3 last year

Get all your
news in one place.

100's of premium titles.
One news app.

The Hindu

Many pharma companies that bought electoral bonds faced regulatory actions

Top pharmaceutical companies purchased electoral bonds amidst regulatory scrutiny, including Hetero, MSN, Divi's, Intas, Lupin, Mankind, Micro Labs, and Natco.

The Independent UK

Two lots of Tydemy birth control pills are under recall. The FDA warns of 'reduced effectiveness'

Federal regulators are warning consumers that now-recalled lots of the Tydemy birth control pill “may have reduced effectiveness” due to decreased levels of a key ingredient of the product

The Independent UK

Netflix: Thieves steal $500,000 from The Crown and Lupin sets

‘Our cast and crew are safe and there were no injuries,’ the streamer said

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.